Drug name - Posimir

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8153149 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8753665 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8846072 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8153661 DURECT Controlled delivery system Sep, 2025

(2 years from now)

Drugs and Companies using BUPIVACAINE ingredient

Treatment: Method for providing sustained local anesthesia for at least 24 hours

Dosage: SOLUTION, EXTENDED RELEASE;INFILTRATION

More Information on Dosage
Strength Dosage Availability
660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE;INFILTRATION Discontinued

availability in other generic markets.

Click on the highlighted region to filter.